Overview

Application of Amyloid PET in Cerebral Amyloid Angiopathy

Status:
Completed
Trial end date:
2018-03-22
Target enrollment:
Participant gender:
Summary
In this project, we will try to enhance the diagnostic potentials of amyloid PET in CAA by combination of dynamic amyloid PET with MRI SWI and MR perfusion images. We will also try to investigate the roles of CAA in patients with drug-related ICH and validate the accuracy of clinical CAA diagnostic criteria. In addition, we will try to study the characteristics of long-term progression of amyloid deposition in CAA patients. This project will enroll 100 patients with ICH, 30 patients with AD, and 30 control subjects. Each patient will receive the above image studies, followed by data analysis and comparison.
Phase:
Phase 3
Details
Lead Sponsor:
National Taiwan University Hospital